ProMIS Neurosciences Inc
TSX:PMN
ProMIS Neurosciences Inc
Operating Income
ProMIS Neurosciences Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ProMIS Neurosciences Inc
TSX:PMN
|
Operating Income
-$23.1m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-26%
|
|
Zymeworks Inc
NYSE:ZYME
|
Operating Income
-$138.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Operating Income
-$116.2m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Operating Income
-$99.2m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Operating Income
-$91.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-36%
|
|
Spectral Medical Inc
TSX:EDT
|
Operating Income
-CA$11.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
0%
|
See Also
What is ProMIS Neurosciences Inc's Operating Income?
Operating Income
-23.1m
USD
Based on the financial report for Mar 31, 2023, ProMIS Neurosciences Inc's Operating Income amounts to -23.1m USD.
What is ProMIS Neurosciences Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-26%
Over the last year, the Operating Income growth was -102%. The average annual Operating Income growth rates for ProMIS Neurosciences Inc have been -51% over the past three years , -30% over the past five years , and -26% over the past ten years .